About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Articles

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices

Citation:

Cardiac Failure Review 2019;5(1):19–23.

Value of Telemonitoring and Telemedicine in Heart Failure Management

Citation:

Cardiac Failure Review 2017;3(2):116–21.

Cardiac Resynchronisation Therapy and Heart Failure: Angle from 5P Medicine

Citation:

Cardiac Failure Review 2015;1(1):35–7

Left Ventricular Assist Devices in the Management of Heart Failure

Citation:

Cardiac Failure Review 2015;1(1):25–30